Jjjjherman said:Hi all,
My wife was just diagnosed with a Glomus Jugulare Tumor and I am not sure if this is the right
spot to ask the question.
We have searched far and wide on the internet and found many definitions and even found a little
(VERY LITTLE) information in the newsgroups areas.
This is probably not much help, but at least confirms what you know so far. Lance
*****
*GLOMUS JUGULARE TUMORS
CLINICAL AND PATHOLOGIC CONSIDERATIONS Glomus jugulare tumors arise from glomus tissue in the
adventitia of the jugular bulb (glomus jugulare) or along Jacobson's nerve in the temporal bone,
sometimes multifocally. The tumor invades temporal bone diffusely, but growth is characteristically
slow. Sometimes they are endocrine active, with a carcinoid or pheochromocytoma-like
syndrome.418glomus jugulare tumors occur in the jugular foramen, they commonly cause lower cranial
nerve palsies and early symptoms of hoarseness and difficulty swallowing. Later, facial weakness,
hearing loss, and atrophy of the tongue become prominent. Pulsating tinnitus also may be a
presenting symptom, and a pulsating mass can sometimes be seen behind the eardrum. A presumptive
radiologic diagnosis of glomus tumor can be made by CT or MRI scanning, with jugular neurilemmoma
being the main differential diagnosis. Because glomus tumors incite a tremendous blood supply,
particularly by way of the ascending pharyngeal artery, cerebral angiography provides the definitive
diagnosis. Because preoperative tumor embolization is essential to surgical removal of glomus
tumors, the diagnostic angiogram should be performed just before surgery when possible.
Histopathologically, numerous vascular channels are distinctive. The background is composed of
clear cells clumped in a fibrous matrix. A small percentage of glomus tumors are malignant.
SURGERY The treatment of glomus jugulare tumors is controversial, with advocates for radiation,
surgery, and the combination. Most clinicians would agree that a resection should be attempted and
that in most instances gross surgical resection, if not a cure, is a realistic goal. Surgery on
glomus tumors is most often performed by a neurosurgeon and a head and neck surgeon together after
preoperative embolization. The base of the skull in the region of the jugular foramen is first
exposed, and neurovascular structures are identified and mobilized through a high transverse
cervical incision. When the incision is extended behind the pinna and a mastoidectomy is completed,
the facial nerve can be protected, and the entire tumor bulb, jugular bulb, and internal jugular
vein can be seen passing through the base of the skull. Finally, after a suboccipital craniectomy,
the sigmoid sinus above and the jugular vein below can be ligated, and the segment between them
excised with the attached tumor. Complications of this procedure include CSF leak and cranial nerve
(particularly facial) palsy.
RADIATION THERAPY Even though glomus tumors are histologically benign, radiation therapy is
effective and has been recommended for symptomatic lesions that cannot be totally resected or as
primary treatment.glomus tumors treated with radiotherapy alone and a 91% local control rate for
glomus tympanicum and jugulare tumors treated with radiotherapy alone or with preoperative or
postoperative irradiation. The dose required for control is relatively modest. Kim and associates
reported a series of 40 patients with such lesions and added a literature survey. 1.4% recurred with
doses of 40 Gy or higher.
Based on these data, a dose of 45 Gy in 5 weeks is recommended. Although a dose of 50 Gy has been
advocated for more advanced tumors, there is no evidence that such lesions require higher doses.
Treatment is usually delivered through a homolateral pair of angled, wedged portals, depending on
the precise location of the lesion. More sophisticated three-dimensional conformal techniques may
be used to reduce the dose to surrounding normal tissue structures.
*From Cancer: Principles and Practice of Oncology [edited by] Vincent T. DeVita, Jr., Samuel
Hellman, Steven A. Rosenberg; 319 contributors.-6th, ISSN 0892-0567, ISBN 0-781-72229-2